Foghorn Therapeutics
FHTX
#8160
Rank
โ‚น16.35 B
Marketcap
โ‚น294.06
Share price
9.21%
Change (1 day)
-50.03%
Change (1 year)

Revenue for Foghorn Therapeutics (FHTX)

Revenue in 2024 (TTM): โ‚น1.89 Billion

According to Foghorn Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น1.93 Billion. a decrease over the revenue in the year 2023 that were of โ‚น2.84 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Foghorn Therapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น1.93 B-31.81%
2023 โ‚น2.84 B78.7%
2022 โ‚น1.59 B1520.7%
2021 โ‚น98.17 M212.18%
2020 โ‚น31.44 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA